Viewing Study NCT05768932

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:34 PM
Ignite Modification Date: 2026-02-24 @ 8:47 AM
Study NCT ID: NCT05768932
Status: RECRUITING
Last Update Posted: 2025-10-15
First Post: 2023-01-29
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia
Sponsor: SillaJen, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Solid Tumor View
None TNBC - Triple-Negative Breast Cancer View
None Gastric Cancer View
None Leukemia Acute Myeloid Leukemia (AML) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None carcinoma View
None paclitaxel View
None BAL0891 View
None tislelizumab View